NCT06457503 2026-04-06
TRANSPARENT
Coherus Oncology, Inc.
Phase 4 Recruiting
Clinical Trials
4 trialsNCT06423235 2026-03-24
ESPTTN
Xintian Pharmaceutical
Phase 4 Recruiting
NCT03573960 2026-03-06
A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer
Eisai Inc.
Phase 4 Completed
NCT07354698 2026-01-21
MHI
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 4 Not yet recruiting